Ziram [zinc, bis (dimethyldithiocarbamate)] is an agricultural dithiocarbamate fungicide. By virtual screening, we have identified that ziram is a potential endocrine disruptor. To investigate its effects on pubertal development of Leydig cells, 35-day-old male Sprague Dawley rats orally received ziram (2 or 4 mg/kg/d) for 4 weeks and immature Leydig cells isolated from 35-day-old rat testes were treated with ziram (0.5-50 lM in vitro). Serum hormones, Leydig cell number and specific gene or protein expression levels after in vivo treatment were determined and medium androgen levels were measured as well as apoptosis of Leydig cells after in vitro treatment were determined. In vivo exposure to ziram lowered testosterone and follicle-stimulating hormone levels, and reduced Leydig cell number, and downregulated Leydig cell specific gene or protein expression levels. Ziram exposure in vitro inhibited androgen production and steroidogenic enzyme activities in Leydig cells by downregulating expression levels of P450 cholesterol side cleavage enzyme (Cyp11a1), 3b-hydroxysteroid dehydrogenase 1 (Hsd3b1), 17a-hydroxylase/17,20-lyase (Cyp17a1), and 17b-hydroxysteroid dehydrogenase 3 (Hsd17b3) via downregulating the steroidogenic factor 1 (Nr5a1) at a concentration as low as 5 lM. In conclusion, ziram exposure disrupts Leydig cell development during puberty possibly via downregulating Nr5a1.
Ziram is a dimethyldithiocarbamate, which is used as an agricultural fungicide (Caldas et al., 2001) . It was first registered in the United States in 1960s as a broad-spectrum fungicide with additional uses added to the label in 1980 (www.epa.gov/ oppsrrd1/REDs/factsheets/ziram_red_fs.pdf). It has been primarily used to treat many fungal diseases in crops such as some fruits, nuts, grain, potatoes, and commercially grown ornamentals (Caldas et al., 2001) . In latex rubber production, ziram can also be applied as an accelerating agent (Matei and Trombetta, 2016) . Human may expose ziram through ingestion or contact. Ziram has been found to be toxic to the immune system (Kanemoto-Kataoka et al., 2015; Li et al., 2014 Li et al., , 2015 Muroi and Tanamoto, 2015) and the nervous system (Fitzmaurice et al., 2014; Matei and Trombetta, 2016) .
Ziram was also found to induce significant increase in the frequency of abnormal sperm in a previous study (Hemavathi and Rahiman, 1993) . By virtual screening, we have identified that ziram is an inhibitor of 11b-hydroxysteroid dehydrogenase 1 (HSD11B1) with IC 50 value of 87.07 lM (Li et al., 2016) . HSD11B1 is a critical enzyme in the Leydig cells to protect from the detrimental effects of excessive glucocorticoids (Ma et al., 2011; Zhou et al., 2011) , and this enzyme begin expressed in rat immature Leydig cells on postnatal day 28 (Phillips et al., 1989) . However, the endocrine disrupting action of ziram in Leydig cell development is largely unknown.
During the pubertal sexual development in rats, on postnatal day 35, Leydig cells are present as the immature Leydig cells (Ge and Hardy, 1998; Shan and Hardy, 1992) , which primarily secrete 5a-androstanediol (DIOL), as 80% of the secreted total androgens (Ge and Hardy, 1998) . Immature Leydig cells need additional 21-28 days until postnatal day 56-63 to develop into adult Leydig cells, which primarily secrete testosterone (Ge and Hardy, 1998) .
In immature Leydig cells, the balance of testosterone biosynthesis and metabolism is the key to the androgen homeostasis. Rat immature Leydig cells were ideal model to study the biosynthesis and metabolism of testosterone, because these cells contain testosterone biosynthetic enzymes: cytochrome P450 cholesterol side cleavage enzyme (CYP11A1, gene Cyp11a1), 3b-hydroxysteroid dehydrogenase 1 (HSD3B1, gene Hsd3b1) (Payne et al., 1997) , cytochrome P450 17a-hydroxylase/17,20-lyase (CYP17A1, gene Cyp17a1), and 17b-hydroxysteroid dehydrogenase 3 (HSD17B3, gene Hsd17b3) (Ge and Hardy, 1998) as well as testosterone metabolizing enzymes 5a-reductase 1 (SRD5A1, gene Srd5a1) and 3a-hydroxysteroid dehydrogenase (HSD3A, gene Akr1c14) (Ge and Hardy, 1998) .
To stimulate steroidogenesis, pituitary-secreted luteinizing hormone (LH) binds to adenylate cyclase-coupled LH receptor (gene Lhcgr), which regulates steroidogenesis of immature Leydig cells (Chen et al., 2016) . Intracellular cAMP is increased after the stimulation of the bound receptor, which in turn causes the acute mobilization of intracellular cholesterol into the inner membrane of the mitochondria via the rate-limiting steroidogenic acute regulatory protein (STAR, gene Star). The high-density lipoprotein receptor (SCARB1, gene Scarb1) also transports cholesterol from circulation into Leydig cells. Cholesterol is catalyzed by CYP11A1 in the inner membrane of the mitochondria and is converted into pregnenolone, which diffuses into the smooth endoplasmic reticulum, where it is converted into progesterone by HSD3B1, then to androstenedione and testosterone sequentially by CYP17A1 and HSD17B3 (Ge and Hardy, 1998) . In the smooth endoplasmic reticulum, SRD5A1 converts testosterone into more potent androgen dihydrotestosterone (DHT). DHT diffuses into the cytosol, where is further catalyzed by HSD3A into DIOL, which is a weak androgen (Ge and Hardy, 1998) .
The intrinsic transcription factors to regulate Leydig cell development are still unknown. One of critical factors for development of Leydig cells is the steroidogenic factor 1 (SF-1, also called NR5A1, gene Nr5a1). SF-1 is essential for the commitment of stem Leydig cells to testosterone-producing Leydig cells (Yang et al., 2017) . How ziram disrupts Leydig cell development and what is the mechanism is not understood. This study will address the effects of ziram on pubertal development of Leydig cells in vitro and in vivo. Animals experiment. A 28-day-old Sprague Dawley rats were fed in a 12 h dark/light cycle under temperature at 23 C 6 2 C, and relative humidity of 45%-55%, with ad libitum access to food and water. Animals were adjusted for a week before they were randomly divided into 3 groups namely the control (0 mg/kg/d, n ¼ 6), low dose (2 mg/kg/d, n ¼ 6) and high dose (4 mg/kg, n ¼ 6). The doses were selected based on a previous study (Pandey et al., 1990) Immature Leydig cell isolation. Eighteen 35-day-old male Sprague Dawley rats were sacrificed by asphyxiation with CO 2 . Testes were removed and Leydig cells were purified as described previously in Ge and Hardy (1998) . In brief, animals were sacrificed in CO 2 tank, testes were removed, perfused with a M199 solution containing collagenase (0.1 mg/ml) via the testicular artery, digested with collagenase (0.25 mg/ml), and DNase (0.25 mg/ml) for 15 min, filtered with nylon mesh, and the cells were separated under Percoll gradient. The cells with density of 1.070-1.088 g/ml were collected and washed. Purities of Leydig cell fractions were evaluated by histochemical staining for HSD3B1 activity, with 0.4 mM etiocholanolone as the steroid substrate and NAD þ as a cofactor (Payne et al., 1980) . The purities of Leydig cells were >95%.
MATERIALS AND METHODS
Leydig cell culture. After isolation, the purified immature Leydig cells were seeded into 24-well culture plated with cell density of 0.05 Â 10 6 cells/well. Leydig cells were cultured in 0.5 ml DMEM:
F12 medium (phenol-free) without (basal) or with hormone and signaling substances as well as steroid substrates, 10 ng/ml LH and 20 lM of various steroid substrates including 22 R-hydroxycholesterol (22 R-OHC), pregnenolone (P5), progesterone (P4), and androstenedione (D4) for 24 h in the presence of 50 lM ziram (ziram was dissolved in ethanol and ethanol was the control). 22 R-OHC, P5, P4, and D4 were used as the substrate of CYP11A1, HSD3B1, CYP17A1, and HSD17B3, respectively. 22 R-OHC was used to replace cholesterol as the substrate of CYP11A1 because of its penetration of cell and mitochondrial membranes. The medium was then collected for DIOL (the primary androgen in immature Leydig cells) and testosterone assay after incubation.
Annexin V and PI assay. Isolated immature Leydig cells were seeded into the 6-well plates with the density of 2.5 Â 10 6 cells/ ml and incubated for 24 h. Cells were divided into 3 groups with or without ziram (0.5, 5, 50 lM) treatments. Cells were cultured for 48 h. To evaluate early and lately apoptotic activity, an Annexin V-FITC/PI Apoptosis Detection Kit (Nanjing KeyGEN Biotech, Nanjing, China) was used as the manufacturer's instructions. Cells were harvested and washed with cold phosphate buffered saline (PBS), and then were resuspended in 200 ll the annexin V-binding buffer. After cells were stained with 5 ll of FITC-labeled annexin V and 5 ll of PI, they were instantly measured using Flow Cytometer (BD FACSAria, USA).
Preparation of mitochondrial, cytosol, and microsomal proteins. Mitochondrial, cytosol, and microsomal preparations of rat testes were done as described previously in Ge et al. (1997) . Testes (from 35-day-old Sprague Dawley male rats) were homogenized in cold 0.01 mM PBS containing 0.25 mM sucrose and centrifuged at 700 Â g for 30 min. The supernatants were collected and centrifuged at 10 000 Â g for another 30 min, and then washed twice to collect mitochondrial pellet. The supernatants of the mitochondrial pellet then were further centrifuged at 105,000 Â g for 1 h twice to collect microsomal pellet and the supernatant as cytosol. Pellets were resuspended and protein concentrations in these fractions were measured using the Bio-Rad Protein Assay Kit (Cat No. 500-0006; Bio-Rad, Hercules, California) according to manufacturer's protocol. Mitochondria were used for CYP11A1 measurement. Microsomes were used for measurement of HSD3B1, CYP11A1, and HSD17B3 enzyme activities. According to pilot studies, the enzymatic reactions below were all still linear by the end of the assays with the substrates used less than 10%. 34 C was used for enzymatic activity assay, due to the fact that in mammals (human and rat) the in vivo testicular (Leydig cells) temperature is 34 C.
Assay of DIOL and testosterone concentrations. DIOL and testosterone concentrations in the medium were measured with the tritium-based RIA as described previously in Ge and Hardy (1998) using the commercial RIA kits (IBL, USA). The minimum detectable concentration of the assay for DIOL and testosterone was 5 pg/ml. The internal control contains 100 pg/ml DIOL or testosterone dissolved in the same culture media. Interassay variation of DIOL and testosterone was within 15%.
ELISA for serum LH and FSH Levels. The serum LH and FSH levels were detected with ELISA kit according to the manufacturer's instructions (Chemicon, California, USA). Briefly, 200 ll samples and 50 ll assay diluent were added to pre-coated 96-well plates. The plates were incubated for 2 h at room temperature, and washed 5 times with washing buffer. 100 lL peroxidaseconjugated IgG antiLH or -FSH of solution was added into each well for 2 h at room temperature. Then plates were washed 5 times. Then, 100 ll substrate buffers were added into each well, and incubated in the dark place for 30 min at room temperature. The enzyme reaction was stopped by 50 ll stop solution. The quantification of LH and FSH levels were obtained by a microplate reader at 550 nm with correction wavelength at 450 nm.
Quantitative polymerase chain reaction. Total RNAs were extracted from immature Leydig cells, testes and pituitaries using Trizol reagent (Invitrogen, Carlsbad, California, USA) according to the manufacturer's instruction. The concentrations of total RNAs were determined by Universal Microplate Spectrophotometer (Thermo, USA) at an OD (optical density) value of 260 nm. The RNA was reversely transcribed into cDNA using random hexamers and MMLV reverse transcriptase by the kit (Promega, CA) according to the manufacturer's instruction. Total cDNAs were used to perform a SYBR Green quantitative polymerase chain reaction (qPCR) Kit (Takara, Otsu, Japan) to analyze the gene expression levels. These genes are membrane receptor genes including Lhcgr, cholesterol transporting genes including Scarb1, Star, and Tspo, steroidogenic enzyme genes including Cyp11a1, Hsd3b1, Cyp17a1, Hsd11b1, Hsd17b3, and Nr5a1, cell cycle genes including Ccnd3, and pituitary relative genes including Lhb and Fshb. qPCR was carried out in a 25-ll reaction volume with SYBR Green detection system (Bio-Rad Laboratories, Inc., Hercules) for up to 40 cycles and the melting curves were always checked afterward. The primers were listed in Supplementary Table 2 . The Ct value was recorded, and the mRNA level of each target gene was measured using standard curve method as previously described (Lin et al., 2008) and was normalized to Rps16 (the house-keeping gene, as the internal control).
Western blot analysis. Eighteen Testes were homogenized and boiled in equal volumes of sample loading buffer, a Tris-Cl buffer (pH 6.8), containing 20% glycerol, 5% sodium dodecyl sulfate, 3.1% dithiothreitol, and 0.001% bromophenol blue. Homogenized samples (50 mg protein) were electrophoresed on 10% polyacrylamide gels containing sodium dodecyl sulfate. Proteins were electrophoretically transferred onto nitrocellulose membranes, and after 1 h exposure to 5% nonfat milk to block nonspecific binding, the membranes were incubated with primary antibodies against the following antigens: LHCGR, SCARB1, STAR, CYP11A1, CYP17A1, HSD3B1, HSD11B1, HSD17B3, SF-1, BAX, BCL2, and b-ACTIN (listed in Supplementary Table 1) . The membranes were then washed and incubated with a 1:5000 dilution of goat antirabbit antiserum that was conjugated to horseradish peroxidase. The washing step was repeated, and immunoreactive bands were visualized by chemiluminescence using a kit (ECL, Amersham, Arlington Heights, Illinois, USA). The intensity of proteins was quantified using Image J software.
Immunohistochemistry. One testis from each rat was used for immunohistochemistry (Vector Laboratories, Inc., Burlingame, California, USA) according to the manufacturer's instructions. The testes were dehydrated in ethanol and xylene and then embedded in paraffin. Six micrometer-thick transverse sections (5 lm) were mounted on glass slides. Avidin-biotin immunostaining was conducted following manufacturer's instructions. Antigen retrieval was performed by microwave irradiation for 10 min in 10 mM (pH 6.0) of citrate buffer, after which endogenous peroxidase was blocked with 0.5% of H 2 O 2 in methanol for 30 min. Sections were then incubated with an CYP11A1 or HSD11B1 polyclonal antibody diluted 1:1000, for 1 h at room temperature. Diaminobenzidine was used for visualizing the antibody-antigen complexes, positive labeling Leydig cells by brown cytoplasmic staining. Mayer hematoxylin was applied in counterstaining. The sections were then dehydrated in graded concentrations of alcohol and cover-slipped with resin (Thermo Fisher Scientific, Waltham, UK). Nonimmune rabbit IgG was used in the incubation of negative control sections with working dilution the same as the primary antibody. The round cells with CYP11A1 staining in the interstitial area represent all Leydig cells, while round cells with HSD11B1 staining in the interstitial area represent the Leydig cells at the advanced stages (Phillips et al., 1989) . Leydig cell numbers were calculated by a stereological method.
Enumeration of Leydig cell number by stereology. To enumerate CYP11A1-or HSD11B1-positive Leydig cell numbers, sampling of testes was performed according to a fractionator method as previously described in Akingbemi et al. (2004) . In brief, 6 testes per group (3 groups for eighty rats) at each time point were used. Identification of all cells in the Leydig cell lineage was done by the staining of CYP11A1, and identification of Leydig cells at the advanced stages was performed by the staining of the HSD11B1 because this biomarker is present in Leydig cells beyond postnatal day 28 (Phillips et al., 1989) . About 10 testis sections per rat were sampled from each testis. The total number of Leydig cells was calculated by multiplying the number of Leydig cells counted in a known fraction of the testis by the inverse of the sampling probability.
Statistics. Student t-test was subjected for analysis to identify significant differences whenever 2 groups (a single concentration of ziram vs control) were compared. Data were subjected to analysis by Kruskal-Wallis test followed by ad hoc Dunnett's multiple comparisons to identify significant differences between the tested groups and the controls whenever there were 3 or more groups (multiple concentrations of ziram vs control) were compared. All experiments were repeated for 3-5 times, depending on the experiments. All data are expressed as means 6 SEM. Difference was regarded as significant at p < .05.
RESULTS

Ziram Reduces Testis and Epididymal Weights
Ziram did not affect rat body weights during the course of treatment. Both doses of ziram lowered testis weight and at the higher dose (4 mg/kg) ziram also reduced epididymal weights (Table 1) .
Ziram Lowers Serum Testosterone and FSH Levels
Both doses of ziram significantly decreased serum testosterone levels after 28 days of treatment ( Figure 1A ) without affecting serum LH levels ( Figure 1B) . Meanwhile, both does of ziram also significantly lowered serum FSH levels ( Figure 1C ). This (PND35 þ 28) . B, LH levels on day 28 (PND35 þ 28). C, FSH levels on day 28 (PND35 þ 28). Mean 6 SE, n ¼ 6. *p < .05, **p < .01, ***p < .001 indicate significant differences when compared with control (0 mg/kg). suggests that ziram could interfere with Leydig cell development and spermatogenesis.
Ziram Delays Leydig Cell Development
All Leydig cells were identified by CYP11A1 because it began expressed in the Leydig cell lineage (Ge and Hardy, 1998) . Leydig cells at immature and adult stages were identified by the staining of HSD11B1, which began expressing in Leydig cells after postnatal day 28 (Phillips et al., 1989) . Brown cytosolic staining in the interstitium showed CYP11A1-or HSD11B1-positive cells. Ziram significantly reduced HSD11B1-positive cell numbers without affecting CYP11A1-positive cell numbers (Figure 2A-J) .
The ratios of HSD11B1-positive cells relative to CYP11A1-positive cells were 1.04, 0.66, and 0.67, respectively. There was one round of cell division of immature Leydig cells from postnatal day 35 to reach adult number of Leydig cells (Hardy et al., 1989) . 
Ziram Downregulates Gene and Their Product Expression Levels of the Testis and Pituitary
We examined the effects of ziram on the expression levels of Leydig cell specific genes: Lhcgr, Scarb1, Star, Cyp11a1, Cyp17a1, Hsd3b1, Hsd11b1, Hsd17b3, and Nr5a1 in the testis on postnatal day 63 after in vivo ziram treatment ( Figure 3A-L) . Ziram significantly downregulated Lhcgr, Star, Hsd3b1, Hsd11b1, Hsd17b3, and Nr5a1 expression levels at ! 2 mg/kg, while at higher dose ziram also downregulated Scarb1, Cyp11a1, and Cyp17a1 levels. Since the number of CYP11A1-positive cells was not altered by ziram, the downregulation of these gene expressions indicates that ziram delayed the differentiation of Leydig cells. We also examined pituitary Lhb and Fshb levels ( Figure 3J and K). Ziram downregulated Fshb expression without affecting Lhb expression, which were in parallel with serum LH and FSH levels.
The protein levels of LHCGR, SCARB1, STAR, CYP11A1, CYP17A1, HSD3B1, HSD11B1, HSD17B3, and SF-1 in the testes on postnatal day 63 were analyzed ( Figure 4A) , and semi-quantitative data showed that the changes of protein levels were in accordance with their mRNA levels ( Figure 4B ).
Ziram Directly Inhibits Immature Leydig Cell Development In Vitro
We treated immature Leydig cells with 0.5, 5, 50 lM ziram for 24 h. Ziram concentration-dependently lowered DIOL plus testosterone (T), DIOL, and T levels ( Figure 5A-C) . This indicates that ziram is a potent inhibitor to block androgen synthesis. We further measured the effects of ziram on the expression levels of Leydig cell genes related with androgen biosynthesis ( Figure  5D ). Ziram significantly downregulated the Tspo and Hsd3b1 levels at ! 0.5 lM, Lhcgr, Scarb1, Star, Cyp17a1, and Hsd17b3 at ! 5 lM, as well as Cyp11a1 and Ccnd3 levels at 50 lM.
The protein levels of LHCGR, SCARB1, STAR, CYP11A1, CYP17A1, HSD3B1, HSD11B1, HSD17B3, and SF-1 in immature Leydig cells were measured ( Figure 6A ). The quantification showed that their levels were mostly in parallel with those of their respective mRNA levels ( Figure 6B ). We also measured CYP11A1, CYP17A1, HSD3B1, and HSD17B3 activities in the Leydig cells and their activities were in parallel with those of their respective protein levels (Supplementary Figure 1) .
We also examined the androgen production by adding LH (10 ng/ml), and steroidogenic enzyme substrates, including these of CYP11A1 (22 R-OHC, 20 lM), HSD3B1 (pregnenolone, P5, 20 lM), CYP17A1 (progesterone, P4, 20 lM), HSD17B3 Mean 6 SE, n ¼ 6. *p < .05, **p < .01, indicate significant differences when compared to the control (0 mg/kg).
(androstenedione, D4, 20 lM) after 24 h-treatment of 50 lM ziram. Data further showed that androgen productions in all sets were lowered (Supplementary Figure 2) . This data showed that even a short-term treatment of ziram at a high concentration (50 lM) also inhibits the androgen production of Leydig cells.
Ziram Induces Immature Leydig Cell Apoptosis
We further used annexin V/PI assay to detect the apoptosis of immature Leydig cells. During the early stages of apoptosis, cells typically had an intact cell membrane that is not stained with propidium iodide (PI). However, externalization of phosphatidylserine can be detected by annexin V. The result showed that ziram significantly promoted the ratio of apoptotic cells in immature Leydig cells ( Figure 7A ). The control group without ziram treatment almost had no apoptotic cells, with only 0.52 6 0.08%. The groups with both dose of ziram (0.5 or 50 lM) treatments contained 7.90% 6 0.36% and 11.47% 6 0.22% apoptotic cells respectively, which were much higher than that of control group, and high dose also had more apoptotic cells than that of low dose ( Figure 7B ).
To elucidate the potential molecular mechanisms involved in ziram-induced Leydig cell apoptosis, the levels of apoptotic signaling molecules in the mitochondria, including BAX and BCL2, were evaluated by Western blot after treatment with ziram (0.5-50 lM). When compared with the control, ziram at ! 0.5 lM could significantly promote BAX and inhibit BCL2 expressions ( Figure 7C and D) .
DISCUSSION
Ziram is wildly used as an agricultural fungicide to control and prevent the spread of fungal infections (Caldas et al., 2001) . A protectant fungicide is not absorbed into the plant and must be applied prior to infection. Ziram is also formulated as a repellent and as an additive in industrial adhesives, caulking and latex paints (De Jong et al., 2002) . The total annual domestic use of ziram is estimated at approximately 1.9 million pounds of active ingredient (Jin et al., 2014) . It has given rise to possible health concerns about its adverse effects on the population.
The potentially negative effects of ziram were examined in this study. The effects of ziram on Leydig cells were first tested in vivo. We found that ziram lowered Leydig cell numbers, inhibited steroidogenic enzyme, and reduced androgen production without affecting pituitary LH secretion as shown the unchanged LH level and Lhb expression in the pituitary. Indeed, in vitro study proved that ziram was a potent inhibitor of Leydig cell specific gene expressions and steroidogenesis. However, we could not exclude the indirect action of ziram since FSH level and Fshb expressions in the pituitary were reduced. These suggest that ziram can affect Leydig cell development via indirectly lowering FSH. The receptor for FSH is located in the Sertoli cell (Ottenweller et al., 2000) . Knockout of FSH receptors clearly reduced Leydig cell numbers and delayed the puberty of mice (O'Shaughnessy et al., 2012) .
This study clearly demonstrated that in vivo exposure to ziram delayed Leydig cell maturation and lowered androgen production. Ziram (as low as 5 lM) in vitro significantly downregulated the expression of Nr5a1, thus lowering the Lhcgr, Scarb1, Star, Cyp11a1, Cyp17a1, Hsd3b1, Hsd11b1, and Hsd17b3 levels as well as androgen production. Ziram at ! 0.5 lM could tein levels. Mean 6 SE, n ¼ 6. *p < .05, **p < .01, ***p < .001 indicate significant differences when compared with the control (0 lM).
induce immature Leydig cell apoptosis through upregulating BAX and downregulating BCL2 protein expression levels.
Both in vivo and in vitro experiments showed that ziram significantly reduced SF-1 expression. Since SF-1 is a critical transcription factor for the Leydig cell development, the zirammediated downregulation of SF-1 could lead to the lower expressions of steroidogenesis-related genes. Indeed, many studies showed that Lhcgr, Star, Cyp11a1, Cyp17a1, Hsd3b1, and Hsd17b3 promoters had SF-1 binding sites (Chen et al., 1999; Hu et al., 2001; Sandhoff et al., 1998; Schimmer et al., 2011) . Although the exact mechanism is still unclear, the significant suppression of SF-1, a critical transcription factor for the expression of steroidogenic enzymes (Ferlay et al., 2015) , especially, Cyp11a1, Cyp17a1, Hsd3b1, and Hsd17b3, by ziram at as low as 5 lM, suggests that ziram may interfere with Sf-1 expression.
In this study, we found that at as low as 0.5 lM ziram induced apoptosis of immature Leydig cells isolated from rat testes on postnatal day 35, at which immature Leydig cells emerge and express HSD11B1, a immaturity biomarker of Leydig cells (Chen et al., 2009 ). There are no 2 populations (immature and adult Leydig cells) in rat testis on postnatal day 35. This study indicates that ziram induces apoptosis in immature Leydig cells. Ziram was also reported to induce apoptosis in a human monocyte-like cell line, U937 (Li et al., 2011) , human natural killer cells (Li et al., 2012a) and human T lymphocytes (Li et al., 2012b) . Ziram-induced apoptosis could act via BCL2/BAX signaling pathway. BAX, a pro-apoptotic and pore-forming cytoplasmic protein in the BCL2 family, translocates to the outer mitochondrial membrane and affects permeability from the inter-membrane space into the cytosol, which later causes cell death (Yu et al., 2011) . Conversely, BCL2, an antiapoptotic protein in the BCL2 family, lies in the cytoplasmic of the outer mitochondrial membrane, nuclear envelope, and endoplasmic reticulum (Chiou et al., 2006; Zhao et al., 2012) . In this study, ziram significantly promoted the expression of BAX and inhibited ziram treatments. Mean 6 SE, n ¼ 6. **p < .01, ***p < .001, indicates significant differences when compared with control (0 lM).
## p < .05 (50 lM vs 0.5 lM) also indicates significant difference.
the expression of BCL2, which further demonstrated that it promoted Leydig cell apoptosis.
In conclusion, ziram exerts impairments on rat Leydig cells and their steroidogenic capacities at lower concentrations (as low as 0.5 lM) possibly via significant downregulation of Sf-1 and thus lower expression levels of some important steroidogenic enzymes and androgen production. In vivo, ziram also delays Leydig cell development during puberty via indirectly lowering the section of FSH.
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